This video highlights trials studying the long-term impact of adjuvant tamoxifen and aromatase inhibitors for the treatment of patients with postmenopausal breast cancer.
Prudence A. Francis, MD
Advertisement
Articles by Prudence A. Francis, MD
This video reviews the impact of the SOFT/TEXT trials for the treatment of patients with premenopausal breast cancer, and ways to best use the results.
Advertisement
Latest Updated Articles
Adjuvant Endocrine Therapy in Postmenopausal Breast CancerPublished: August 25th 2017 | Updated:
Impact of SOFT/TEXT in Premenopausal Breast CancerPublished: August 25th 2017 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
How Will ESMO 2025 Data Shape the Future of Genitourinary Cancer Care?
2
Single-Agent PD-1 Blockade Therapy Improves Responses in Desmoplastic Melanoma
3
Real-World Data From IMS: Promising Results in Relapsed/Refractory Multiple Myeloma
4
64Cu-SAR-bisPSMA PET Detects More Prostate Cancer Lesions vs SOC
5
